Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Pharma Industry News RECOVERY coronavirus trial : First patients enrolled in COVID-19 clinical trial by University of Oxford RECOVERY coronavirus trial : University of Oxford researchers in the UK have initiated a coronavirus clinical trial called… bySrinathMarch 26, 2020
